Sel-J Pharmaceuticals’ Ampicillin Sulbactam (with brand name Unasan) wins the patent case filed against them by Pfizer, owner of the leading innovator brand Unasyn. The case, initially filed by Pfizer in October 2008, alleges that…
Sel-J Pharmaceuticals’ Ampicillin Sulbactam (with brand name Unasan) wins the patent case filed against them by Pfizer, owner of the leading innovator brand Unasyn. The case, initially filed by Pfizer in October 2008, alleges that…